The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...
New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...
For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...
In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human whole genome ...
"Fueled by advances in NGS and precision medicine, China’s DNA sequencing market sees rapid growth amid strong government support, rising clinical applications, and innovation hubs in Guangdong, ...
Giovanna Prout joins Countable Labs as CEO to accelerate commercialization of Countable Labs’ products Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a ...
ESMO 2025 showcased the breadth and urgency of breast cancer research, which remains one of the most diagnosed malignancies ...
A global team of experts from academia and industry has joined forces in a landmark Consensus Statement on next-generation ...
Liver cancer screening uses ultrasound and AFP biomarker tests, with CT or MRI for further evaluation if abnormalities are ...
This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from ...
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of the next generation of its high-performance Flex assay, featuring automation-compatible ...
Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback